Entry Detail



General Information

Database ID:exR0083831
RNA Name:TUBB
RNA Type:mRNA
Chromosome:chr6
Starnd:+
Coordinate:
Start Site(bp):30720352End Site(bp):30725426
External Links:ENSG00000196230



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AIF1L
chr9
131096476
131123152
+
AHI1
chr6
135283532
135497765
-
AC091959.3
chr5
146203550
146339251
+
ADGRL2
chr1
81306160
81992436
+
AL022238.4
chr22
40346529
40410054
+
ACADS
chr12
120725774
120740008
+
AC015813.2
chr17
57989038
58007246
-
AATF
chr17
36948954
37056871
+
AACS
chr12
125065434
125143333
+
AKR1A1
chr1
45550543
45570049
+
AC025165.3
chr12
57772660
57797554
+
ADGRV1
chr5
90529344
91164437
+
AGO1
chr1
35869808
35930532
+
ABHD10
chr3
111979010
111993368
+
AC010132.3
chr7
42909273
42932174
-
ACAP1
chr17
7336529
7351477
+
AC048338.1
chr12
122207779
122266423
-
AC006030.1
chr2
74211604
74363377
-
ADH5
chr4
99070978
99088801
-
ACBD6
chr1
180269653
180502954
-
AAMP
chr2
218264123
218270257
-
AIG1
chr6
143060496
143341058
+
ACTB
chr7
5527148
5563784
-
AC013394.1
chr15
92883413
92949230
+
AL590132.1
chr1
210858125
211134146
-
AHSA1
chr14
77457870
77469472
+
ALDH18A1
chr10
95605941
95656711
-
AKAP8
chr19
15353385
15379798
-
ACTG1
chr17
81509971
81523847
-
ACTR3
chr2
113890063
113962596
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-92a-3p
chrX
134169544
134169565
-
hsa-miR-3198
chr12
54231407
54231428
-
hsa-miR-3654
chr7
133034860
133034878
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002470.2
chr22
20979462
20998121
+
AC004687.1
chr17
58330884
58332508
-
AC010729.1
chr2
5726253
5730355
+
AC012360.3
chr2
105334027
105337475
-
AC016876.2
chr17
7581964
7584086
-
AC019205.1
chr6
73263212
73301789
+
AC022167.2
chr16
8848105
8860456
+
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC068134.1
chr2
232379635
232381674
-
AC092171.3
chr7
5426277
5428927
-
AC099522.2
chr5
73497550
73498293
-
AC114271.1
chr19
10333436
10336248
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL023653.1
chrX
129794994
129796963
+
AL049543.1
chr6
28587378
28591747
+
AL132780.1
chr14
22929607
22956374
+
AL133215.2
chr10
101060029
101061005
-
AL137058.2
chr13
52600042
52642542
+
AL137127.1
chr1
19072110
19075511
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA